Lynda Harper

504 total citations
15 papers, 270 citations indexed

About

Lynda Harper is a scholar working on Infectious Diseases, Virology and General Health Professions. According to data from OpenAlex, Lynda Harper has authored 15 papers receiving a total of 270 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Infectious Diseases, 9 papers in Virology and 2 papers in General Health Professions. Recurrent topics in Lynda Harper's work include HIV/AIDS drug development and treatment (10 papers), HIV Research and Treatment (9 papers) and HIV/AIDS Research and Interventions (9 papers). Lynda Harper is often cited by papers focused on HIV/AIDS drug development and treatment (10 papers), HIV Research and Treatment (9 papers) and HIV/AIDS Research and Interventions (9 papers). Lynda Harper collaborates with scholars based in United Kingdom, France and Italy. Lynda Harper's co-authors include Diana M. Gibb, Carlo Giaquinto, Alexandra Compagnucci, Gareth Tudor‐Williams, Ross E. McKinney, Ann J. Melvin, Yacine Saïdi, Hannah Castro, Linda Harrison and Mary E. Smith and has published in prestigious journals such as PEDIATRICS, The Lancet Infectious Diseases and AIDS.

In The Last Decade

Lynda Harper

14 papers receiving 264 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lynda Harper United Kingdom 8 234 159 51 51 16 15 270
Jean-Marc Chapplain France 10 156 0.7× 92 0.6× 59 1.2× 40 0.8× 27 1.7× 16 231
Ivan Mambule United Kingdom 10 150 0.6× 91 0.6× 66 1.3× 31 0.6× 32 2.0× 22 213
Adriana Durán Argentina 8 180 0.8× 136 0.9× 33 0.6× 46 0.9× 17 1.1× 13 211
Jhon Rojas Spain 11 296 1.3× 141 0.9× 77 1.5× 86 1.7× 9 0.6× 19 355
Yao Abo Ivory Coast 6 229 1.0× 93 0.6× 135 2.6× 58 1.1× 19 1.2× 12 265
Shalton Mwaringa United Kingdom 6 143 0.6× 123 0.8× 46 0.9× 15 0.3× 13 0.8× 7 182
Neena Bodasing United Kingdom 7 174 0.7× 66 0.4× 96 1.9× 44 0.9× 22 1.4× 15 269
Girish Prajapati United States 10 249 1.1× 95 0.6× 179 3.5× 172 3.4× 19 1.2× 25 436
Vasiliki Chounta United Kingdom 9 218 0.9× 144 0.9× 95 1.9× 50 1.0× 10 0.6× 18 252
Sorakij Bhakeecheep Thailand 11 302 1.3× 210 1.3× 96 1.9× 93 1.8× 17 1.1× 19 352

Countries citing papers authored by Lynda Harper

Since Specialization
Citations

This map shows the geographic impact of Lynda Harper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lynda Harper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lynda Harper more than expected).

Fields of papers citing papers by Lynda Harper

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lynda Harper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lynda Harper. The network helps show where Lynda Harper may publish in the future.

Co-authorship network of co-authors of Lynda Harper

This figure shows the co-authorship network connecting the top 25 collaborators of Lynda Harper. A scholar is included among the top collaborators of Lynda Harper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lynda Harper. Lynda Harper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Bielicki, Julia, David Dunn, Saul N. Faust, et al.. (2021). Amoxicillin duration and dose for community-acquired pneumonia in children: the CAP-IT factorial non-inferiority RCT. Health Technology Assessment. 25(60). 1–72. 7 indexed citations
2.
Freguja, Riccardo, Alasdair Bamford, Marisa Zanchetta, et al.. (2020). Long‐term clinical, virological and immunological outcomes following planned treatment interruption in HIV‐infected children. HIV Medicine. 22(3). 172–184. 2 indexed citations
3.
4.
Hind, Daniel, Barnaby C Reeves, Sarah Bathers, et al.. (2017). Comparative costs and activity from a sample of UK clinical trials units. Trials. 18(1). 203–203. 15 indexed citations
5.
Butler, Karina, Jamie Inshaw, Deborah Ford, et al.. (2016). BREATHER (PENTA 16) short-cycle therapy (SCT) (5 days on/2 days off) in young people with chronic human immunodeficiency virus infection: an open, randomised, parallel-group Phase II/III trial. Health Technology Assessment. 20(49). 1–108. 13 indexed citations
6.
Harrison, Linda, Ann J. Melvin, Susan A. Fiscus, et al.. (2015). HIV-1 Drug Resistance and Second-Line Treatment in Children Randomized to Switch at Low Versus Higher RNA Thresholds. JAIDS Journal of Acquired Immune Deficiency Syndromes. 70(1). 42–53. 7 indexed citations
7.
Yin, Dwight E., Meredith G. Warshaw, William C. Miller, et al.. (2014). Using CD4 Percentage and Age to Optimize Pediatric Antiretroviral Therapy Initiation. PEDIATRICS. 134(4). e1104–e1116. 13 indexed citations
8.
Forcat, Silvia, Hermione Lyall, Tim R. Cressey, et al.. (2013). Pharmacokinetics of Pediatric Lopinavir/Ritonavir Tablets in Children When Administered Twice Daily According to FDA Weight Bands. The Pediatric Infectious Disease Journal. 33(3). 301–305. 6 indexed citations
9.
10.
Baiardi, Paola, Oscar Della Pasqua, Lynda Harper, et al.. (2009). Clinical trials for paediatric medicines in Europe. Pharmaceuticals Policy and Law. 11(1,2). 71–78. 1 indexed citations
11.
Gibb, Diana M., Deenan Pillay, Karina Butler, et al.. (2007). Lamivudine/abacavir maintains virological superiority over zidovudine/lamivudine and zidovudine/abacavir beyond 5 years in children. AIDS. 21(8). 947–955. 48 indexed citations
12.
Green, Hannah, Diana M. Gibb, Alexandra Compagnucci, et al.. (2006). A Randomized Controlled Trial of Genotypic HIV Drug Resistance Testing in HIV-1-Infected Children: The Pera (Penta 8) Trial. Antiviral Therapy. 11(7). 857–868. 12 indexed citations
13.
Litalien, Catherine, Alexandra Compagnucci, Carlo Giaquinto, et al.. (2003). Pharmacokinetics of nelfinavir and its active metabolite, hydroxy-tert-butylamide, in infants perinatally infected with human immunodeficiency virus type 1. Paediatric European Network for Treatment of AIDS Executive Committee. UCL Discovery (University College London).
14.
Litalien, Catherine, Albert Faye, Alexandra Compagnucci, et al.. (2003). Pharmacokinetics of nelfinavir and its active metabolite, hydroxy-tert-butylamide, in infants perinatally infected with human immunodeficiency virus type 1. The Pediatric Infectious Disease Journal. 22(1). 48–55. 25 indexed citations
15.
Carrière, Isabelle, JH Darbyshire, Carlo Giaquinto, et al.. (1998). A randomized double-blind trial of the addition of lamivudine or matching placebo to current nucleoside analogue reverse transcriptase inhibitor therapy in HIV-infected children: The PENTA-4 trial. UCL Discovery (University College London). 12(14). 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jean-Marc Chapplain Breakdown of academic impact, for papers by Ivan Mambule Breakdown of academic impact, for papers by Adriana Durán Breakdown of academic impact, for papers by Jhon Rojas Breakdown of academic impact, for papers by Yao Abo Breakdown of academic impact, for papers by Shalton Mwaringa Breakdown of academic impact, for papers by Neena Bodasing Breakdown of academic impact, for papers by Girish Prajapati Breakdown of academic impact, for papers by Vasiliki Chounta Breakdown of academic impact, for papers by Sorakij Bhakeecheep
Rankless by CCL
2026